Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tight Control Dose Reductions of Biologics in Psoriasis Patients With Low Disease Activity: A Randomized Pragmatic Trial

NCT02602925 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT02602925
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02602925 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tight Control Dose Reductions of Biologics in Psoriasis Patients With Low Disease Activity: A Randomized Pragmatic Trial
Lead sponsor
Radboud University Medical Center
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2016
Completion date
July 20, 2018
Enrollment
120 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis